Overview


According to FutureWise analysis the market for Vaccine Administration Devices in 2023 is US$ 4.33 billion, and is expected to reach US$ 8.08 billion by 2031 at a CAGR of 8.10%.

A vaccination is a chemical that is injected into the body to prevent infection or disease caused by a pathogen, such as a virus, bacteria, or parasite. By triggering an immunological reaction, the vaccine instructs the body on how to defend itself against the disease. Preventive vaccinations operate by delivering a small component or a non-harmful form of the pathogen (known as the foreign antigen) into the body, which protects the individual from infection or sickness. Antibodies (through the humoral reaction), killer cells (by the cell mediated response), or both are produced in the body in response to the pathogen. Inactivated/killed vaccinations, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines are examples of vaccine types. Using a syringe or needle, vaccines are delivered intramuscularly or subcutaneously. Vaccine administration devices include features such as the development of novel vaccines, which will have an impact on manufacturers launching new products into the market, increasing demand, as well as the rising burden of infectious diseases, which leads to the demand for precise vaccine administration in order to elicit a strong immune response on delivery of targeted vaccines. Various research studies are now being conducted, which are likely to give producers with a competitive advantage in developing new and novel vaccine administration devices, as well as other opportunities in the vaccine administration devices market. The vaccine administration devices market is likely to be restrained in the forecast period due to the difficulty of mucosal delivery of vaccinations and patients' phobia of injections and needle sticks.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Vaccine Administration Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Vaccine Administration Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • BD
  • Terumo Europe Nv (A Subsidiary Of Terumo Corporation)
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Schott Ag (A Subsidiary Of Carl-zeiss-stiftung)
  • 3M
  • Antares Pharma
  • Bespak Europe Ltd.
  • Corium Inc.
  • D'antonio Consultants International, Inc.
  • Enesi
  • Ihealthnet Llc.
  • Injex Uk
  • Inovio Pharmaceuticals
  • Medical International Technologies (Mit Canada) Inc.
  • Micropoint Technolgies
  • Mylan Pharmaceuticals Inc. (A Subsidiary Of Mylan N.V.)
  • Mystic Pharmaceuticals
  • Nanopass
  • Pharmajet
  • Star Syringe Limited
  • Vaxxas Pty. Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Auto Injector
    • Intramuscular
    • Subcutaneous
  • Jet Injectors
    • Disposable Cartridge Jet Injector (Dcji) With Prefilled Unit Dose Cartridges
    • Single-use Disposable Jet Injectors (Sudji)
    • Disposable Cartridge Jet Injectors (Dcji): End-user Filling.
    • Solid Particle Jet Injectors
  • Micro Needles
    • Hollow Microneedles
    • Vaccine -coated Microneedles
    • Dissolvable/biodegradable Microneedles
    • Solid Microneedles
  • Inhalation/pulmonary Delivery
    • Powder Inhalation
    • Liquid Inhalation
  • Microinjection Systems
  • Pen-injector Devices
  • Biodegradable Implants
  • Electroporation-based Needle Free Injection Systems
  • Buccal / Sublingual Vaccine Delivery Systems
  • Auto-injector Trainer Devices
  • Other Devices

By Route of Administration

  • Intramuscular Vaccination
  • Subcutaneous Vaccination
  • Intradermal Vaccination

By Type

  • Marketed- Vaccines
    • Syringes
    • Autoinjectors
      • Intramuscular
      • Subcutaneuos
    • Jet Injectors
    • Microneedles
    • Aerosol/dry Powder Inhalation
    • Microinjection System
    • Biodegradable Implants
    • Electroporation- Based Needle Free Injection Systems
    • Buccal /sublingual Vaccine Delivery Systems
    • Others Devices
  • Clinical- Stage Vaccines

By Brand

  • Bd Accuspray Nasal Spray System
  • Bd Hypak For Vaccines Glass Pre-fillable Syringe System
  • Bd Uniject Auto-disable Pre-fillable Injection System
  • Plajex
  • Gx Rtf Clearject
  • Gx Innosafe
  • Others

By Vaccine Type

  • Bivalent Oral Polio Vaccine
  • Bcg Vaccine
  • Tetanus-diphtheria Vaccine
  • Dtp-hepb-hib Vaccine
  • Influenza Vaccine
  • Pneumococcal Conjugate Vaccine
  • Measles Vaccine
  • Others

By Modality

  • Automatic Vaccine Administration Device
  • Manual Vaccine Administration Device

By Usability

  • Disposable
  • Reusable

By End User

  • Hospitals
  • Community Centers
  • Homecare Setting
  • Research And Academic Institutes
  • Ambulatory Surgical Center
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Vaccine Administration Devices Market By Product, By Route of Administration, By Type, By Brand, By Vaccine Type, By Modality, By Usability, By End User, and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Vaccine Administration Devices Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Vaccine Administration Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Vaccine Administration Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Vaccine Administration Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Auto Injector
         1.1. Intramuscular
         1.2. Subcutaneous
        2. Jet Injectors
         2.1. Disposable Cartridge Jet Injector (Dcji) With Prefilled Unit Dose Cartridges
         2.2. Single-use Disposable Jet Injectors (Sudji)
         2.3. Disposable Cartridge Jet Injectors (Dcji): End-user Filling.
         2.4. Solid Particle Jet Injectors
        3. Micro Needles
         3.1. Hollow Microneedles
         3.2. Vaccine -coated Microneedles
         3.3. Dissolvable/biodegradable Microneedles
         3.4. Solid Microneedles
        4. Inhalation/pulmonary Delivery
         4.1. Powder Inhalation
         4.2. Liquid Inhalation
        5. Microinjection Systems
        6. Pen-injector Devices
        7. Biodegradable Implants
        8. Electroporation-based Needle Free Injection Systems
        9. Buccal / Sublingual Vaccine Delivery Systems
        10. Auto-injector Trainer Devices
        11. Other Devices

  • 8.   Vaccine Administration Devices Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Intramuscular Vaccination
        2. Subcutaneous Vaccination
        3. Intradermal Vaccination

  • 9.   Vaccine Administration Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Marketed- Vaccines
         1.1. Syringes
         1.2. Autoinjectors
          1.2.1. Intramuscular
          1.2.2. Subcutaneuos
         1.3. Jet Injectors
         1.4. Microneedles
         1.5. Aerosol/dry Powder Inhalation
         1.6. Microinjection System
         1.7. Biodegradable Implants
         1.8. Electroporation- Based Needle Free Injection Systems
         1.9. Buccal /sublingual Vaccine Delivery Systems
         1.10. Others Devices
        2. Clinical- Stage Vaccines

  • 10.   Vaccine Administration Devices Market, By Brand Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bd Accuspray Nasal Spray System
        2. Bd Hypak For Vaccines Glass Pre-fillable Syringe System
        3. Bd Uniject Auto-disable Pre-fillable Injection System
        4. Plajex
        5. Gx Rtf Clearject
        6. Gx Innosafe
        7. Others

  • 11.   Vaccine Administration Devices Market, By Vaccine Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bivalent Oral Polio Vaccine
        2. Bcg Vaccine
        3. Tetanus-diphtheria Vaccine
        4. Dtp-hepb-hib Vaccine
        5. Influenza Vaccine
        6. Pneumococcal Conjugate Vaccine
        7. Measles Vaccine
        8. Others

  • 12.   Vaccine Administration Devices Market, By Modality Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Automatic Vaccine Administration Device
        2. Manual Vaccine Administration Device

  • 13.   Vaccine Administration Devices Market, By Usability Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Disposable
        2. Reusable

  • 14.   Vaccine Administration Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Community Centers
        3. Homecare Setting
        4. Research And Academic Institutes
        5. Ambulatory Surgical Center
        6. Others

  • 15.   North America Vaccine Administration Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 16.   Latin America Vaccine Administration Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 17.   Europe Vaccine Administration Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 18.   Asia Pacific Vaccine Administration Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 19.   Middle East and Africa Vaccine Administration Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 20.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 21.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. BD
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Terumo Europe Nv (A Subsidiary Of Terumo Corporation)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Gerresheimer AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. West Pharmaceutical Services, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Schott Ag (A Subsidiary Of Carl-zeiss-stiftung)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. 3M
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Antares Pharma
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bespak Europe Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Corium Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. D'antonio Consultants International, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Enesi
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Ihealthnet Llc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Injex Uk
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Inovio Pharmaceuticals
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Medical International Technologies (Mit Canada) Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Micropoint Technolgies
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Mylan Pharmaceuticals Inc. (A Subsidiary Of Mylan N.V.)
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Mystic Pharmaceuticals
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Nanopass
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Pharmajet
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. Star Syringe Limited
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. Vaxxas Pty. Ltd.
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview

  • 22.   Pre and Post COVID-20 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-20 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 23.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients